| Literature DB >> 24050945 |
Yasmeen Q Rizvi1, Chander S Mehta, Adebayo Oyekan.
Abstract
Hypoxia and adenosine are known to upregulate angiogenesis; however, the role of peroxisome proliferator-activated receptor alpha (PPARα) in angiogenesis is controversial. Using transgenic Tg(fli-1:EGFP) zebrafish embryos, interactions of PPARα and adenosine receptors in angiogenesis were evaluated under hypoxic conditions. Epifluorescent microscopy was used to assess angiogenesis by counting the number of intersegmental (ISV) and dorsal longitudinal anastomotic vessel (DLAV) at 28 h post-fertilization (hpf). Hypoxia (6h) stimulated angiogenesis as the number of ISV and DLAV increased by 18-fold (p<0.01) and 100 ± 8% (p<0.001), respectively, at 28 hpf. Under normoxic and hypoxic conditions, WY-14643 (10 μM), a PPARα activator, stimulated angiogenesis at 28 hpf, while MK-886 (0.5 μM), an antagonist of PPARα, attenuated these effects. Compared to normoxic condition, adenosine receptor activation with NECA (10 μM) promoted angiogenesis more effectively under hypoxic conditions. Involvement of A2B receptor was implied in hypoxia-induced angiogenesis as MRS-1706 (10nM), a selective A2B antagonist attenuated NECA (10 μM)-induced angiogenesis. NECA- or WY-14643-induced angiogenesis was also inhibited by miconazole (0.1 μM), an inhibitor of epoxygenase dependent production of eicosatrienoic acid (EET) epoxide. Thus, we conclude that: activation of PPARα promoted angiogenesis just as activation of A2B receptors through an epoxide dependent mechanism.Entities:
Keywords: 5′-N-ethylcarboxamidoadenosine; Adenosine receptors; Angiogenesis; CYP2C9; DLAV; EET; Eicosatrienoic acid; HIF-1α; IL-8; ISV; NECA; PGAR; PPARα; PPARγ; PPARγ angiopoietin-related gene; TSP-1; Tg(fli-1:EGFP); Zebrafish; cytochrome P450 2C9; dorsal longitudinal anastomotic vessel; eicosatrienoic acid; hour post-fertilization; hpf; hypoxia-inducible factor-1 alpha; interleukin-8; intersegmental vessel; peroxisome proliferator-activated receptor alpha; peroxisome proliferator-activated receptor gamma; thrombospondin-1; transgenic friendly leukemia integration-1 enhanced green fluorescent protein
Mesh:
Substances:
Year: 2013 PMID: 24050945 PMCID: PMC3876467 DOI: 10.1016/j.vph.2013.09.001
Source DB: PubMed Journal: Vascul Pharmacol ISSN: 1537-1891 Impact factor: 5.773